MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 42 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $128,134 | +83.0% | 11,181 | -40.1% | 0.00% | – |
| Q3 2022 | $70,000 | -38.1% | 18,681 | -1.6% | 0.00% | – |
| Q2 2022 | $113,000 | -23.1% | 18,981 | -18.1% | 0.00% | – |
| Q1 2022 | $147,000 | +47.0% | 23,181 | -9.7% | 0.00% | – |
| Q4 2021 | $100,000 | -36.3% | 25,681 | -20.9% | 0.00% | – |
| Q3 2021 | $157,000 | -41.6% | 32,481 | -23.0% | 0.00% | -100.0% |
| Q2 2021 | $269,000 | -72.9% | 42,166 | -73.4% | 0.00% | -66.7% |
| Q1 2021 | $994,000 | -34.5% | 158,245 | -28.1% | 0.00% | -25.0% |
| Q4 2020 | $1,517,000 | – | 220,110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 22NW, LP | 749,302 | $2,892,000 | 1.80% |
| Clearline Capital LP | 316,425 | $1,221,000 | 0.84% |
| Newtyn Management, LLC | 888,620 | $3,430,000 | 0.67% |
| Western Standard LLC | 150,363 | $580,000 | 0.54% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 222,467 | $859,000 | 0.40% |
| BVF INC/IL | 721,935 | $2,787,000 | 0.36% |
| Sepio Capital, LP | 411,676 | $1,589,000 | 0.12% |
| Yakira Capital Management, Inc. | 66,934 | $258,000 | 0.09% |
| J. Goldman & Co LP | 152,095 | $587,000 | 0.04% |
| Spark Investment Management LLC | 48,909 | $188,000 | 0.01% |